Stocks
Exact Sciences CorporationEXAS
NASDAQHealthcareDiagnostics & Research$103.57+0.29%
A molecular diagnostics company focused on cancer screening and precision oncology testing, best known for its stool-based colorectal cancer screening test, Cologuard. The firm develops and commercializes tests that use DNA and other biomarkers to detect cancer and guide treatment decisions. Investo...
Market Cap: $19.8B52W Range: $38.81 – $103.75
Congressional Interest in Exact Sciences Corporation (EXAS)
10 members of Congress have disclosed 36 trades in Exact Sciences Corporation (EXAS), a Healthcare company. The buy/sell breakdown shows 16 purchases versus 20 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
36
Unique Politicians
10
Buys
16
Sells
20
Who in Congress Is Trading EXAS?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2024-05-10 | Josh Gottheimer | sell | $1K – $15K |
| 2024-02-01 | Josh Gottheimer | sell | $1K – $15K |